Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease - PubMed (original) (raw)
Meta-Analysis
doi: 10.3945/ajcn.112.044545. Epub 2013 Jul 3.
Guillaume Pare, Stephen M Schwartz, Aditi Hazra, Toshiko Tanaka, Sita H Vermeulen, Ioana Cotlarciuc, Xin Yuan, Anders Mälarstig, Stefania Bandinelli, Joshua C Bis, Henk Blom, Morris J Brown, Constance Chen, Yii-Der Chen, Robert J Clarke, Abbas Dehghan, Jeanette Erdmann, Luigi Ferrucci, Anders Hamsten, Albert Hofman, David J Hunter, Anuj Goel, Andrew D Johnson, Sekar Kathiresan, Ellen Kampman, Douglas P Kiel, Lambertus A L M Kiemeney, John C Chambers, Peter Kraft, Jan Lindemans, Barbara McKnight, Christopher P Nelson, Christopher J O'Donnell, Bruce M Psaty, Paul M Ridker, Fernando Rivadeneira, Lynda M Rose, Udo Seedorf, David S Siscovick, Heribert Schunkert, Jacob Selhub, Per M Ueland, Peter Vollenweider, Gérard Waeber, Dawn M Waterworth, Hugh Watkins, Jacqueline C M Witteman, Martin den Heijer, Paul Jacques, Andre G Uitterlinden, Jaspal S Kooner, Dan J Rader, Muredach P Reilly, Vincent Mooser, Daniel I Chasman, Nilesh J Samani, Kourosh R Ahmadi
Affiliations
- PMID: 23824729
- PMCID: PMC4321227
- DOI: 10.3945/ajcn.112.044545
Meta-Analysis
Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease
Joyce B J van Meurs et al. Am J Clin Nutr. 2013 Sep.
Abstract
Background: The strong observational association between total homocysteine (tHcy) concentrations and risk of coronary artery disease (CAD) and the null associations in the homocysteine-lowering trials have prompted the need to identify genetic variants associated with homocysteine concentrations and risk of CAD.
Objective: We tested whether common genetic polymorphisms associated with variation in tHcy are also associated with CAD.
Design: We conducted a meta-analysis of genome-wide association studies (GWAS) on tHcy concentrations in 44,147 individuals of European descent. Polymorphisms associated with tHcy (P < 10(⁻⁸) were tested for association with CAD in 31,400 cases and 92,927 controls.
Results: Common variants at 13 loci, explaining 5.9% of the variation in tHcy, were associated with tHcy concentrations, including 6 novel loci in or near MMACHC (2.1 × 10⁻⁹), SLC17A3 (1.0 × 10⁻⁸), GTPB10 (1.7 × 10⁻⁸), CUBN (7.5 × 10⁻¹⁰), HNF1A (1.2 × 10⁻¹²)), and FUT2 (6.6 × 10⁻⁹), and variants previously reported at or near the MTHFR, MTR, CPS1, MUT, NOX4, DPEP1, and CBS genes. Individuals within the highest 10% of the genotype risk score (GRS) had 3-μmol/L higher mean tHcy concentrations than did those within the lowest 10% of the GRS (P = 1 × 10⁻³⁶). The GRS was not associated with risk of CAD (OR: 1.01; 95% CI: 0.98, 1.04; P = 0.49).
Conclusions: We identified several novel loci that influence plasma tHcy concentrations. Overall, common genetic variants that influence plasma tHcy concentrations are not associated with risk of CAD in white populations, which further refutes the causal relevance of moderately elevated tHcy concentrations and tHcy-related pathways for CAD.
Figures
FIGURE 1.
Manhattan plot of a meta-analysis of 10 genome-wide association studies for total plasma total homocysteine concentrations. Genome-significant associations were defined as P = 5 × 10−8 and are depicted by a gray line. Novel total homocysteine genes/loci that are described for the first time in this article are shown in bold gray font.
References
- Casas JP, Bautista LE, Smeeth L, Sharma P, Hingorani AD. Homocysteine and stroke: evidence on a causal link from Mendelian randomisation. Lancet 2005;365:224–32. - PubMed
- Den Heijer M, Lewington S, Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J Thromb Haemost 2005;3:292–9. - PubMed
- Nelen WL. Hyperhomocysteinaemia and human reproduction. Clin Chem Lab Med 2001;39:758–63. - PubMed
- Morris MS. Homocysteine and Alzheimer's disease. Lancet Neurol 2003;2:425–8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 HL087676/HL/NHLBI NIH HHS/United States
- UL1RR033176/RR/NCRR NIH HHS/United States
- R03CA133937-01A1/CA/NCI NIH HHS/United States
- N01-HC-85085/HC/NHLBI NIH HHS/United States
- SP/04/002/BHF_/British Heart Foundation/United Kingdom
- N01-HC-85082/HC/NHLBI NIH HHS/United States
- MOP--82810/CAPMC/ CIHR/Canada
- R01HL089650-02/HL/NHLBI NIH HHS/United States
- HL080295/HL/NHLBI NIH HHS/United States
- 263 MD 9164/MD/NIMHD NIH HHS/United States
- 084723/Z/08/Z/WT_/Wellcome Trust/United Kingdom
- N02-HL-6-4278/HL/NHLBI NIH HHS/United States
- N01-HC-25195/HC/NHLBI NIH HHS/United States
- G0601966/MRC_/Medical Research Council/United Kingdom
- N01-HC-55022/HC/NHLBI NIH HHS/United States
- N01-HC-85081/HC/NHLBI NIH HHS/United States
- HL105756/HL/NHLBI NIH HHS/United States
- N01-HC-55016/HC/NHLBI NIH HHS/United States
- 263 MD 821336/MD/NIMHD NIH HHS/United States
- AG-15928/AG/NIA NIH HHS/United States
- DH_/Department of Health/United Kingdom
- P01 HL098055/HL/NHLBI NIH HHS/United States
- HL054711/HL/NHLBI NIH HHS/United States
- R01 AR/AG 41398/AG/NIA NIH HHS/United States
- AG-20098/AG/NIA NIH HHS/United States
- HL087652/HL/NHLBI NIH HHS/United States
- UL1 TR000124/TR/NCATS NIH HHS/United States
- N01-HC-55021/HC/NHLBI NIH HHS/United States
- MC_U137686857/MRC_/Medical Research Council/United Kingdom
- N01-HC-85086/HC/NHLBI NIH HHS/United States
- R01DK080732/DK/NIDDK NIH HHS/United States
- R01 HL105756/HL/NHLBI NIH HHS/United States
- AG-027058/AG/NIA NIH HHS/United States
- P30 DK063491/DK/NIDDK NIH HHS/United States
- HL075366/HL/NHLBI NIH HHS/United States
- N01-HC-35129/HC/NHLBI NIH HHS/United States
- N01 HC-55222/HC/NHLBI NIH HHS/United States
- N01-HC-55019/HC/NHLBI NIH HHS/United States
- MOP77682/CAPMC/ CIHR/Canada
- P01HL087018/HL/NHLBI NIH HHS/United States
- N01-HC-55015/HC/NHLBI NIH HHS/United States
- N01-HC-85083/HC/NHLBI NIH HHS/United States
- 1R01HL103931-01/HL/NHLBI NIH HHS/United States
- N01-HC-55020/HC/NHLBI NIH HHS/United States
- N01-HC-85080/HC/NHLBI NIH HHS/United States
- N01 HC-15103/HC/NHLBI NIH HHS/United States
- 090532/WT_/Wellcome Trust/United Kingdom
- N01-HC-75150/HC/NHLBI NIH HHS/United States
- ARC_/Arthritis Research UK/United Kingdom
- ImNIH/Intramural NIH HHS/United States
- N01-AG-12100/AG/NIA NIH HHS/United States
- DK063491/DK/NIDDK NIH HHS/United States
- N01-HC-45133/HC/NHLBI NIH HHS/United States
- N01-HC-85079/HC/NHLBI NIH HHS/United States
- N01-HC-85239/HC/NHLBI NIH HHS/United States
- MOP172605/CAPMC/ CIHR/Canada
- N01-HC-55018/HC/NHLBI NIH HHS/United States
- HL087647/HL/NHLBI NIH HHS/United States
- AG-023629/AG/NIA NIH HHS/United States
- CRUK_/Cancer Research UK/United Kingdom
- N01-HC-85084/HC/NHLBI NIH HHS/United States
- P01HL076491-06/HL/NHLBI NIH HHS/United States
- G0700931/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous